Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q2 2025 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Atea Pharmaceuticals' Second Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.